替拉扎明结构式
|
常用名 | 替拉扎明 | 英文名 | Tirapazamine |
|---|---|---|---|---|
| CAS号 | 27314-97-2 | 分子量 | 178.148 | |
| 密度 | 1.7±0.1 g/cm3 | 沸点 | 493.6±28.0 °C at 760 mmHg | |
| 分子式 | C7H6N4O2 | 熔点 | 220ºC | |
| MSDS | 中文版 美版 | 闪点 | 252.3±24.0 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
替拉扎明用途Tirapazamine是一种抗癌剂,对实体瘤中的缺氧细胞具有选择性细胞毒性,从而诱导DNA中的单链和双链断裂,碱基损伤和细胞死亡。 |
| 中文名 | 替拉扎明 |
|---|---|
| 英文名 | tirapazamine |
| 中文别名 | 3-氨基-1,2,4-苯并三嗪-1,4-二氧 | 替扎拉明 |
| 英文别名 | 更多 |
| 描述 | Tirapazamine是一种抗癌剂,对实体瘤中的缺氧细胞具有选择性细胞毒性,从而诱导DNA中的单链和双链断裂,碱基损伤和细胞死亡。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.7±0.1 g/cm3 |
|---|---|
| 沸点 | 493.6±28.0 °C at 760 mmHg |
| 熔点 | 220ºC |
| 分子式 | C7H6N4O2 |
| 分子量 | 178.148 |
| 闪点 | 252.3±24.0 °C |
| 精确质量 | 178.049072 |
| PSA | 89.83000 |
| LogP | -0.31 |
| 外观性状 | 橙色-红色结晶粉末 |
| 蒸汽压 | 0.0±1.3 mmHg at 25°C |
| 折射率 | 1.777 |
| 储存条件 | 0-10°C;避免加热 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| 危害码 (欧洲) | Xi: Irritant; |
| 风险声明 (欧洲) | 36/37/38 |
| 安全声明 (欧洲) | 26-36 |
| 危险品运输编码 | NONH for all modes of transport |
| RTECS号 | DM0671500 |
|
An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.
J. Biomed. Mater. Res. B. Appl. Biomater. 103(3) , 618-28, (2015) Three-dimensional (3-D) tissue engineered constructs provide a platform for examining how the local extracellular matrix contributes to the malignancy of various cancers, including human glioblastoma ... |
|
|
Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels.
Oxid. Med. Cell. Longev. 2012 , 890826, (2012) Doxorubicin (DOX) causes long-term cardiomyopathy that is dependent on oxidative stress and contractility disorders. Tirapazamine (TP), an experimental adjuvant drug, passes the same red-ox transforma... |
|
|
Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
Br. J. Cancer 77 Suppl 4 , 12-4, (1998) Human solid tumours are composed of a significant proportion of hypoxic cells, i.e. cells with oxygen levels lower than those of normal tissues. Tumour hypoxic cells have been shown to have a negative... |
| 4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine |
| 1,2,4-Benzotriazin-3-amine, 1,4-dioxide |
| 3-Amino-1,2,4-benzotriazine 1,4-Dioxide |
| 1,4-Dioxido-1,2,4-benzotriazin-3-ylamine |
| SR 259075 |
| 1,2,4-Benzotriazin-3-amine 1,4-dioxide |
| 4-Hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine SR 259075 SR 4233 Tirazone Win 59075 |
| Tirazone |
| Tirapazamine |
| 3-Aminobenzo[e][1,2,4]triazine 1,4-dioxide |